News: IMM Immutep Receives Constructive Regulatory Feedback On TACTI-004 Registrational Trial In...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Dec 21 (Reuters) - Immutep Ltd (IMM) :

    • IMMUTEP RECEIVES CONSTRUCTIVE REGULATORY FEEDBACK ON TACTI-004 REGISTRATIONAL TRIAL IN METASTATIC NON-SMALL CELL LUNG CANCER
    • IMMUTEP LTD - PLANS TO ANNOUNCE ITS FINAL TRIAL DESIGN FOR TACTI-004 IN Q1 OF CY2024
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $337.6M
Open High Low Value Volume
24.0¢ 24.0¢ 23.0¢ $244.5K 1.043M

Buyers (Bids)

No. Vol. Price($)
20 392012 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 126850 6
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.